Titan Pharmaceuticals
TTNP
#10414
Rank
โ‚น0.55 B
Marketcap
โ‚น414.15
Share price
-3.76%
Change (1 day)
31.11%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น394.38. In 2023 the company made an earnings per share (EPS) of -โ‚น665.69 an increase over its 2022 EPS that were of -โ‚น1,365.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น665.69-51.22%
2022-โ‚น1,365-15.61%
2021-โ‚น1,617-81.37%
2020-โ‚น8,678-77.52%
2019-โ‚น38,612-56.32%
2018-โ‚น88,400-59.51%
2017-โ‚น2,18,348-371.81%
2016โ‚น80,330-144.35%
2015-โ‚น1,81,112300%
2014-โ‚น45,278-121.54%
2013โ‚น2,10,219-151.38%
2012-โ‚น4,09,119-11.54%
2011-โ‚น4,62,482188.89%
2010-โ‚น1,60,090-10%
2009-โ‚น1,77,878
2007-โ‚น7,29,298-2.38%
2006-โ‚น7,47,086-39.13%
2005-โ‚น12,27,356-16.87%
2004-โ‚น14,76,385-22.43%
2003-โ‚น19,03,2914.9%
2002-โ‚น18,14,35261.9%
2001-โ‚น11,20,629-13.7%
2000-โ‚น12,98,50765.01%
1999-โ‚น7,86,939-35.87%
1998-โ‚น12,27,147-1824.71%
1997โ‚น71,151-102.4%
1996-โ‚น29,70,557

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Vanda Pharmaceuticals
VNDA
-โ‚น127.57-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น21.56-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น303.65-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น937.84-337.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น661.20-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Repligen
RGEN
โ‚น2.70-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA